CA2540586A1 - Traitement d'un trouble chez un mammifere par administration d'une sucre amine et utilisations associees - Google Patents

Traitement d'un trouble chez un mammifere par administration d'une sucre amine et utilisations associees Download PDF

Info

Publication number
CA2540586A1
CA2540586A1 CA002540586A CA2540586A CA2540586A1 CA 2540586 A1 CA2540586 A1 CA 2540586A1 CA 002540586 A CA002540586 A CA 002540586A CA 2540586 A CA2540586 A CA 2540586A CA 2540586 A1 CA2540586 A1 CA 2540586A1
Authority
CA
Canada
Prior art keywords
aminosugar
group
infra
cartilage
joint
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002540586A
Other languages
English (en)
Inventor
Youe-Kong Shue
Franklin W. Okumu
Alexander R. Shikhman
Martin Lotz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Optimer Pharmaceuticals LLC
Original Assignee
Optimer Pharmaceuticals, Inc.
Youe-Kong Shue
Franklin W. Okumu
Alexander R. Shikhman
Martin Lotz
The Scripps Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Optimer Pharmaceuticals, Inc., Youe-Kong Shue, Franklin W. Okumu, Alexander R. Shikhman, Martin Lotz, The Scripps Research Institute filed Critical Optimer Pharmaceuticals, Inc.
Publication of CA2540586A1 publication Critical patent/CA2540586A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
CA002540586A 2003-10-01 2004-09-30 Traitement d'un trouble chez un mammifere par administration d'une sucre amine et utilisations associees Abandoned CA2540586A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50771603P 2003-10-01 2003-10-01
US60/507,716 2003-10-01
PCT/US2004/032048 WO2005034961A1 (fr) 2003-10-01 2004-09-30 Traitement d'un trouble chez un mammifere par administration d'une sucre amine et utilisations associees

Publications (1)

Publication Number Publication Date
CA2540586A1 true CA2540586A1 (fr) 2005-04-21

Family

ID=34434891

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002540586A Abandoned CA2540586A1 (fr) 2003-10-01 2004-09-30 Traitement d'un trouble chez un mammifere par administration d'une sucre amine et utilisations associees

Country Status (5)

Country Link
EP (1) EP1670486A4 (fr)
JP (1) JP2007507516A (fr)
CN (1) CN1909911A (fr)
CA (1) CA2540586A1 (fr)
WO (1) WO2005034961A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005072268A2 (fr) * 2004-01-20 2005-08-11 Optimer Pharmaceuticals, Inc. Traitement des pathologies cartilagineuses degeneratives chez les mammiferes au moyen d'inhibiteurs de la glycosidase
EP2318014B1 (fr) * 2008-07-18 2016-09-14 Genís hf. Nouvelle composition pour le traitement de troubles auto-immuns
KR101098581B1 (ko) * 2009-01-09 2011-12-26 서울대학교산학협력단 Ａｂｈ 항원을 이용한 염증질환 개선용 조성물
CN103384528B (zh) * 2010-11-24 2016-04-13 杜雷科特公司 生物可降解的药物递送组合物
CN102614111B (zh) * 2012-04-05 2013-11-06 苏州豫源生物医药有限公司 氨基葡萄糖的凝胶剂及其制备方法
CN105884720A (zh) * 2016-04-23 2016-08-24 陈斌 一种盐酸丁螺环酮的药物组合物及其医药用途
WO2020104833A1 (fr) * 2018-11-19 2020-05-28 4P-Pharma Composition et procédés pour réguler la prolifération de chondrocytes et augmenter la production de matrice cartilagineuse
CN112169713A (zh) * 2020-09-09 2021-01-05 江南大学 一种n-烷基乳糖胺表面活性剂小分子醇凝胶及其制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3927723A1 (de) * 1989-01-26 1990-08-02 Ulrich Prof Dr Speck N - acetylglucosamin zur buccalen anwendung
AUPM666894A0 (en) * 1994-07-07 1994-07-28 University Of Melbourne, The Diagnostic methods and compositions
EP0855908B1 (fr) * 1995-12-11 2002-02-06 Omni Nutraceuticals, Inc. Regime alimentaire a base de complements nutritionnels permettant de soulager les symptomes de l'arthrite
US5840715A (en) * 1995-12-11 1998-11-24 Inholtra Investment Holdings & Trading, N.V. Dietary regimen of nutritional supplements for relief of symptoms of arthritis
EP0957925B1 (fr) * 1996-12-13 2005-04-20 Lescarden, Inc. Traitement de l'arthrose par administration de poly-n-acetyl-d-glucosamine
US6514983B1 (en) * 1997-09-03 2003-02-04 Guilford Pharmaceuticals Inc. Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
US6378527B1 (en) * 1998-04-08 2002-04-30 Chondros, Inc. Cell-culture and polymer constructs
US6514522B2 (en) * 1998-04-08 2003-02-04 Chondros, Inc. Polymer constructs
EP1077944A1 (fr) * 1998-05-15 2001-02-28 Guilford Pharmaceuticals Inc. Composes de carboxamide, compositions et methodes d'inhibition de l'activite de type poly(adp-ribose) polymerase (parp)
US6506785B2 (en) * 1998-05-22 2003-01-14 Pfizer, Inc. Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives
US6656925B2 (en) * 1998-09-09 2003-12-02 Advanced Medical Instruments Composition and method of treating arthritis
US6346519B1 (en) * 1998-09-09 2002-02-12 Advanced Medical Instruments Method and composition for treating arthritis
US6662805B2 (en) * 1999-03-24 2003-12-16 The Johns Hopkins University Method for composite cell-based implants
ATE424111T1 (de) * 2001-03-29 2009-03-15 Scripps Research Inst Formulierungen, die eingeschlossene wirkstoffe enthalten, und ihre verwendung
IS6085A (is) * 2001-09-26 2003-03-27 Genis Ehf. Lyfjablanda með kítósan óligómerum
MXPA01011542A (es) * 2001-11-13 2003-05-22 Alcon Inc Regeneracion del cartilago articular da°ado por la osteoartritis de grado i y ii, mediante la aplicacion intra-articular de una mezcla de hialuronato de sodio y de condroitin sulfato en un vehiculo de gel.
JP2003225093A (ja) * 2001-11-30 2003-08-12 Sumitomo Pharmaceut Co Ltd 軟骨障害マーカー及びその利用
HUP0402135A3 (en) * 2001-11-30 2008-04-28 Pfizer Controlled release implant forming polymeric compositions of bone growth promoting compounds and process for their preparation

Also Published As

Publication number Publication date
EP1670486A4 (fr) 2009-04-01
CN1909911A (zh) 2007-02-07
EP1670486A1 (fr) 2006-06-21
WO2005034961A1 (fr) 2005-04-21
JP2007507516A (ja) 2007-03-29

Similar Documents

Publication Publication Date Title
JP6113424B2 (ja) 安定化された多糖の処方のための組成物及び方法
Brandt Effects of nonsteroidal anti-inflammatory drugs on chondrocyte metabolism in vitro and in vivo
CA2653660C (fr) Acide hyaluronique sulfate destine au traitement de l'arthrose degenerative
US9216193B2 (en) Crosslinked hyaluronic acid composition and self-crosslinking hyaluronic acid particles
Shikhman et al. Chondroprotective activity of N-acetylglucosamine in rabbits with experimental osteoarthritis
JP5600192B2 (ja) 関節疾患に対する持続的治療効果を有する薬剤
EP2252290B1 (fr) Composition pharmaceutique pour le traitement ou la prévention de maladies ostéo-articulaires
CN114010640A (zh) 创伤后骨关节炎的预防性治疗
EP3463304A1 (fr) Compositions comprenant du cannabidiol et de l'acide hyaluronique pour le traitement de maladies inflammatoires des articulations
US20070197471A1 (en) Treatment of degenerative cartilage conditions in a mammal with Glycosidasc Inhibitors
US10842810B2 (en) Continuous release compositions made from hyaluronic acid, and therapeutic applications of same
Jean et al. Hyaluronic acid attenuates osteoarthritis development in the anterior cruciate ligament‐transected knee: association with excitatory amino acid release in the joint dialysate
JP2016132669A (ja) 関節を治療するための組成物及び方法
Sayed Aly Intra-articular drug delivery: a fast growing approach
US20070142326A1 (en) Treatment of a condition in a mammal with administration of aminosugar and uses thereof
CA2540586A1 (fr) Traitement d'un trouble chez un mammifere par administration d'une sucre amine et utilisations associees
WO2010017265A2 (fr) Compositions injectables à libération prolongée et méthodes de traitement de l’arthrite avec celles-ci
WO2005051326A2 (fr) Traitement d'un etat chez un mammifere par administration de composes, et methodes d'utilisation desdits composes
CN114259463B (zh) 一种靶向补体蛋白发挥抗炎作用的PF-HA-diSE水凝胶及其制备方法与应用
Bierbrauer et al. Biocompatible hydrogel for intra-articular implantation comprising cationic and anionic polymers of natural origin: In vivo evaluation in a rabbit model. Polymers (Basel). 2021; 13 (24): 4426
KR20190140190A (ko) 디아세린 나노입자를 포함하는 관절강 주사용 조성물 및 이의 용도
WO2024089046A1 (fr) Forme posologique pour injection intra-articulaire comprenant de la colchicine et un agent anesthésique dans le traitement de l'arthrite inflammatoire aiguë associée ou non à des cristaux

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead